نتایج جستجو برای: gatifloxacin

تعداد نتایج: 626  

Journal: :Investigative ophthalmology & visual science 2008
Brandt J Wiskur Michael L Robinson Allison J Farrand Billy D Novosad Michelle C Callegan

PURPOSE Bacillus cereus causes the most virulent and refractory form of endophthalmitis. The authors analyzed the effectiveness of early treatment with vancomycin or gatifloxacin, with or without dexamethasone, for experimental B. cereus endophthalmitis. METHODS Rabbit eyes were injected intravitreally with 100 colony-forming units of B. cereus. At 2, 4, or 6 hours after infection, eyes were ...

Journal: :Antimicrobial agents and chemotherapy 2005
C N Paramasivan S Sulochana G Kubendiran P Venkatesan D A Mitchison

The bactericidal activity of gatifloxacin, alone and in combination with isoniazid and rifampin, was studied on both exponential- and stationary-phase cultures of Mycobacterium tuberculosis strain H37Rv. On log-phase cultures, the bactericidal activity of gatifloxacin at 4 microg/ml was rapid and was very similar to that of isoniazid. At concentrations of 0.25 and 4 microg/ml, gatifloxacin enha...

Journal: :Antimicrobial agents and chemotherapy 2001
G A Tarshis B M Miskin T M Jones J Champlin K J Wingert J D Breen M J Brown

This was a double-blind, multicenter study in which 410 adults (> or =18 years of age) with uncomplicated skin and soft tissue infections (SSTIs) were randomized to receive either 400 mg of gatifloxacin orally once daily or 500 mg of levofloxacin orally once daily for 7 to 10 days. The study protocol called for four assessments-before and during treatment, at the end of treatment, and posttreat...

Journal: :Archives of ophthalmology 2006
Darlene Miller Patrick M Flynn Ingrid U Scott Eduardo C Alfonso Harry W Flynn

OBJECTIVE To evaluate the in vitro susceptibility and cross-resistance of gatifloxacin and moxifloxacin vs older fluoroquinolones among coagulase-negative staphylococci recovered from patients with clinical endophthalmitis. METHODS A combination of E tests and disk diffusion methods was used to determine in vitro susceptibility and cross-resistance for 111 coagulase-negative staphylococci iso...

Journal: :Archives of ophthalmology 2004
Joon-Young Hyon Myung-Jin Joo Stacey Hose Debasish Sinha James D Dick Terrence P O'Brien

OBJECTIVE To determine the comparative efficacy of topical gatifloxacin with ciprofloxacin, fortified amikacin, and clarithromycin against Mycobacterium chelonae keratitis in an animal model. METHODS Experimental M chelonae keratitis was induced via intrastromal inoculation in a rabbit model. Thirty-five rabbits were randomly divided into 5 groups and each group was treated hourly for 12 hour...

Journal: :PLoS ONE 2007
Anil Pandit Amit Arjyal Jeremy N. Day Buddhi Paudyal Sabina Dangol Mark D. Zimmerman Bharat Yadav Kasia Stepniewska James I. Campbell Christiane Dolecek Jeremy J. Farrar Buddha Basnyat

OBJECTIVE To assess the efficacy of gatifloxacin versus cefixime in the treatment of uncomplicated culture positive enteric fever. DESIGN A randomized, open-label, active control trial with two parallel arms. SETTING Emergency Room and Outpatient Clinics in Patan Hospital, Lagankhel, Lalitpur, Nepal. PARTICIPANTS Patients with clinically diagnosed uncomplicated enteric fever meeting the i...

Journal: :Archives of ophthalmology 2003
Seenu M Hariprasad William F Mieler Eric R Holz

OBJECTIVE To investigate the penetration of gatifloxacin, a novel extended-spectrum fourth-generation fluoroquinolone antibiotic, into the vitreous and aqueous humor after oral administration. METHODS A prospective, nonrandomized study of 24 consecutive patients scheduled for pars plana vitrectomy between September 2001 and May 2002 at the Cullen Eye Institute. Aqueous, vitreous, and serum sa...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004
Robert Gaynes David Rimland Edna Killum H Ken Lowery Theodore M Johnson George Killgore Fred C Tenover

To determine the cause of an increase in the rate of Clostridium difficile-associated diarrhea (CDAD) in a long-term care facility (LTCF), we analyzed CDAD cases among LTCF patients from October 2001 through June 2002. CDAD cases were identified from review of all enzyme immunoassays positive for C. difficile toxin A. The increase coincided with a formulary change from levofloxacin to gatifloxa...

2011
Ha Vinh Vo Thi Cuc Anh Nguyen Duc Anh James I. Campbell Nguyen Van Minh Hoang Tran Vu Thieu Nga Nguyen Thi Khanh Nhu Pham Van Minh Cao Thu Thuy Pham Thanh Duy Le Thi Phuong Ha Thi Loan Mai Thu Chinh Nguyen Thi Thu Thao Nguyen Thi Hong Tham Bui Li Mong Phan Van Be Bay Jeremy N. Day Christiane Dolecek Nguyen Phu Huong Lan To Song Diep Jeremy J. Farrar Nguyen Van Vinh Chau Marcel Wolbers Stephen Baker

BACKGROUND The bacterial genus Shigella is the leading cause of dysentery. There have been significant increases in the proportion of Shigella isolated that demonstrate resistance to nalidixic acid. While nalidixic acid is no longer considered as a therapeutic agent for shigellosis, the fluoroquinolone ciprofloxacin is the current recommendation of the World Health Organization. Resistance to n...

Journal: :The Journal of antimicrobial chemotherapy 2007
Helen McIlleron Jennifer Norman Thomas P Kanyok P Bernard Fourie John Horton Peter J Smith

OBJECTIVES Pharmacokinetic drug-drug interactions were investigated between the fluoroquinolone gatifloxacin and a fixed dose combination (FDC) of rifampicin, isoniazid and pyrazinamide. PATIENTS AND METHODS The single-dose pharmacokinetics of the four drugs was evaluated in an open-label three-way cross-over study amongst 22 healthy volunteers following administration of gatifloxacin, the FD...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید